
AstraZeneca’s pipeline has suffered another blow with the troubled company halting development of an investigational sepsis drug following poor Phase …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

